Publications by authors named "Iman Abdelhady Elshnoudy"
Article Synopsis
- Difelikefalin is a new medicine approved to help people with kidney problems who have itching, which can make life tough for them.
- A study looked at how well Difelikefalin works compared to a fake treatment (placebo) and found that it helps reduce itching but can cause some side effects.
- More research is needed to see if Difelikefalin is really as good as it seems, since there aren't many studies done yet.
Article Synopsis
- Zuranolone is a newly FDA-approved neurosteroid that shows promise in effectively treating depression, based on recent clinical findings.
- Data from eight studies indicated significant improvements in depression symptoms, particularly with 30mg and 50mg doses, showing over 50% reductions in HAM-D scores within 15 days.
- The drug has shown favorable safety and tolerability profiles, with no significant differences in adverse events like headaches compared to placebo, especially with the 30mg dose.
Background: Rabies is a fatal infectious viral disease that affects all warm-blooded mammals, including humans. Rabid dogs are commonly found in Egypt.
Aims: By assessing the knowledge, attitudes, and practices towards Rabies in Gharbia Governorate, Egypt, this KAP study aimed to improve knowledge of the populations dealing with infected wounds and rabid animals.